📰 Peripheralt Cell Lymphomas News
Peripheralt Cell Lymphomas News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Peripheralt Cell Lymphomas. Real-time updates on events, politics, business and more.
December 21, 2023
- SLS009 Demonstrated Promising Efficacy in Phase 1 Study with 36.4% Clinical Response in r/r Peripheral T-cell Lymphomas ; ORR in r/r PTCL Patients with Standard of Care is 25.8% - - One Patient...
October 30, 2023
- SLS009 Demonstrated Promising Efficacy in Phase 1 Study with 36.4% Clinical Response (ORR) in r/r Peripheral T-cell Lymphomas (PTCL); ORR in r/r PTCL...
February 3, 2023
/PRNewswire/ -- Owen A. OConnor, M.D., Ph.D., is being recognized by Continental Whos Who as a Most Trusted Healthcare Provider and for his contributions in...
September 26, 2022
Summary Histone Deacetylase 2 (Transcriptional Regulator Homolog RPD3 or YY1 Associated Factor 1 or HDAC2 or EC 3. 5. ...
September 21, 2022
/PRNewswire/ -- Owen A. OConnor, M.D., Ph.D., is being recognized by Continental Whos Who as a Top Pinnacle Achiever for inventing and developing many drugs...
September 21, 2022
/PRNewswire/ -- Owen A. OConnor, M.D., Ph.D., is being recognized by Continental Whos Who as a Top Pinnacle Achiever for inventing and developing many drugs...
May 26, 2022
/PRNewswire/ -- Owen A. OConnor, M.D., Ph.D., is being recognized by Continental Whos Who as a Distinguished Medical Oncologist for inventing and developing...
February 2, 2021
Peripheral T-cell Lymphoma Market to exhibit a CAGR of 9.46% during the forecast period of 2020-2030, announces DelveInsight LAS VEGAS, Feb. 2, 2021 /PRNewswire/ -- DelveInsights " Peripheral T-Cell Lymphoma (PTCL) Market" report provides an absolute comprehension of the PTCL, historical and forecasted epidemiology and the Peripheral T-Cell Lymphoma market trends in the 7MM [the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan]. The Peripheral T-Cell Lymphoma mar...